A Novel 3D Osteoblast and Osteocyte Model Revealing Changes in Mineralization and Pro-osteoclastogenic Paracrine Signaling During Estrogen Deficiency.
Authors
Naqvi, Syeda MasoomaPanadero Pérez, Juan Alberto
Kumar, Vatsal
Verbruggen, Anneke S K
McNamara, Laoise M
Issue Date
2020-06-10Keywords
3D cultureestrogen deficiency
mechanical stimulation
mineralization
osteoblasts
osteocytes
Metadata
Show full item recordJournal
Frontiers in bioengineering and biotechnologyDOI
10.3389/fbioe.2020.00601PubMed ID
32656194Abstract
Recent in vitro studies have revealed that the mechanobiological responses of osteoblasts and osteocytes are fundamentally impaired during estrogen deficiency. However, these two-dimensional (2D) cell culture studies do not account for in vivo biophysical cues. Thus, the objectives of this study are to (1) develop a three-dimensional (3D) osteoblast and osteocyte model integrated into a bioreactor and (2) apply this model to investigate whether estrogen deficiency leads to changes in osteoblast to osteocyte transition, mechanosensation, mineralization, and paracrine signaling associated with bone resorption by osteoclasts. MC3T3-E1s were expanded in media supplemented with estrogen (17β-estradiol). These cells were encapsulated in gelatin-mtgase before culture in (1) continued estrogen (E) or (2) no further estrogen supplementation. Constructs were placed in gas permeable and water impermeable cell culture bags and maintained at 5% CO2 and 37°C. These bags were either mechanically stimulated in a custom hydrostatic pressure (HP) bioreactor or maintained under static conditions (control). We report that osteocyte differentiation, characterized by the presence of dendrites and staining for osteocyte marker dentin matrix acidic phosphoprotein 1 (DMP1), was significantly greater under estrogen withdrawal (EW) compared to under continuous estrogen treatment (day 21). Mineralization [bone sialoprotein (BSP), osteopontin (OPN), alkaline phosphatase (ALP), calcium] and gene expression associated with paracrine signaling for osteoclastogenesis [receptor activator of nuclear factor kappa-β ligand (RANKL)/osteoprotegerin OPG ratio] were significantly increased in estrogen deficient and mechanically stimulated cells. Interestingly, BSP and DMP-1 were also increased at day 1 and day 21, respectively, which play a role in regulation of biomineralization. Furthermore, the increase in pro-osteoclastogenic signaling may be explained by altered mechanoresponsiveness of osteoblasts or osteocytes during EW. These findings highlight the impact of estrogen deficiency on bone cell function and provide a novel in vitro model to investigate the mechanisms underpinning changes in bone cells after estrogen deficiency.Item Type
ArticleLanguage
enISSN
2296-4185ae974a485f413a2113503eed53cd6c53
10.3389/fbioe.2020.00601
Scopus Count
Collections
Related articles
- Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
- Authors: Allison H, Holdsworth G, McNamara LM
- Issue date: 2020 Nov 4
- Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model.
- Authors: Simfia I, Schiavi J, McNamara LM
- Issue date: 2020 Jul 1
- Estrogen withdrawal from osteoblasts and osteocytes causes increased mineralization and apoptosis.
- Authors: Brennan MÁ, Haugh MG, O'Brien FJ, McNamara LM
- Issue date: 2014 Jul
- Osteocytes and Estrogen Deficiency.
- Authors: McNamara LM
- Issue date: 2021 Dec
- Osteocyte viability and regulation of osteoblast function in a 3D trabecular bone explant under dynamic hydrostatic pressure.
- Authors: Takai E, Mauck RL, Hung CT, Guo XE
- Issue date: 2004 Sep